Full Text View
Tabular View
No Study Results Posted
Related Studies
Aflibercept in Treating Patients With Advanced Refractory, Relapsed, or Untreated Acute Myeloid Leukemia
This study is not yet open for participant recruitment.
Study NCT00601991.   Last updated on February 6, 2009.
Information provided by National Cancer Institute (NCI)
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Leukemia
Additional conditions recognized in this trial
Leukemia, Myeloid
Leukemia, Myeloid, Acute
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
aflibercept
flow cytometry
immunoenzyme technique
laboratory biomarker analysis
pharmacological study
biopsy
Sponsors listed in this trial
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services